In this episode of the “CURE® Talks Cancer” podcast, we spoke with Dr. Naveen Pemmaraju, associate professor of Leukemia at The University of Texas MD Anderson Cancer Center, who recently conducted research on disease awareness in patients with myeloproliferative neoplasms (MPNs).
Many patients with MPNs reported going to the internet to seek out information about their disease; however, many still did not know about some of the common markers of their disease. While the internet can be a great source of information, there is plenty of misinformation available, too, so it is always important that patients take what they find online and talk to their providers about it.
Read more: https://www.curetoday.com/view/how-to-find-reliable-cancer-information-online
Podcast
Social Media and Rare Cancers: Stay Informed, But Tread With Caution
Author(s):
Social media and the internet as a whole can offer a wealth of information and connections for patients with cancer, especially those with rarer diseases. However, patients should always bring the online advice to their health care team, says Dr. Naveen Pemmaraju.
In this episode of the “CURE® Talks Cancer” podcast, we spoke with Dr. Naveen Pemmaraju, associate professor of Leukemia at The University of Texas MD Anderson Cancer Center, who recently conducted research on disease awareness in patients with myeloproliferative neoplasms (MPNs).
Many patients with MPNs reported going to the internet to seek out information about their disease; however, many still did not know about some of the common markers of their disease. While the internet can be a great source of information, there is plenty of misinformation available, too, so it is always important that patients take what they find online and talk to their providers about it.
Read more: https://www.curetoday.com/view/how-to-find-reliable-cancer-information-online
Newsletter
Stay up to date on cancer updates, research and education
AI Tool May Better Predict Transplant Risk in Myelofibrosis
Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine
Jakafi May Not Associate with Long-Term Benefits in Myelofibrosis Subset
Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research
From Patient 3737 to Advocate: The Life-Changing Power of Clinical Trials
FDA Accepts sNDA for Welireg in Advanced Pheochromocytoma and Paraganglioma
AI Tool May Better Predict Transplant Risk in Myelofibrosis
Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine
Jakafi May Not Associate with Long-Term Benefits in Myelofibrosis Subset
Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research
From Patient 3737 to Advocate: The Life-Changing Power of Clinical Trials
FDA Accepts sNDA for Welireg in Advanced Pheochromocytoma and Paraganglioma